Intent to Sole Source Qiagen Rotor-Gene Q 5plex Cycler
Closed Special Notice Posted
- Solicitation number
- 2024-87704
- Agency
-
CDC Office of Acquisition Services
Centers for Disease Control and Prevention, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Place of performance
- Atlanta, Georgia 30329, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Centers for Disease Control and Prevention (CDC) has issued a Special Notice for the intent to award a sole source firm fixed price purchase order to Qiagen LLC for a Rotor-Gene Q 5plex Platform and RGQ, IQ/OQ Service. The Qiagen Rotor-Gene Q 5plex cyclers are the most popular real-time PCR equipment used in the European region, with over 160 WHO-supported polio diagnostic labs utilizing them. This contract action is being pursued under the authority of FAR 13.106-1(b) and 10 U.S.C. 2304(c)(1).
The purpose of this Special Notice is to inform interested parties of the CDC's intent to sole source this requirement to Qiagen LLC. The Qiagen Rotor-Gene Q 5plex Platform is a unique design that cannot be replaced by other real-time PCR machines on the market, making it a sole source item. Interested parties have until August 2, 2024 at 11:00 EDT to submit any responses or proposals, which will be considered by the government, though this is not a request for competitive quotations. The government will make a determination, at its sole discretion, on whether to proceed with a competitive procurement based on the responses received.
Notice text
The Centers for Disease Control and Prevention intends to award a sole source firm fixed price purchase order to Qiagen LLC for a Rotor-Gene Q 5plex Platform and RGQ, IQ/OQ Service. The Qiagen Rotor-Gene Q 5plex cyclers are the most popular real-time PCR equipment in the European region, with over 160 WHO-supported polio diagnostic labs using them. Use of the Qiagen Rotor-Gene Q 5plex Platform is a requirement of the WHO for a reference laboratory to be able to evaluate the performance of the standardized molecular assays for Poliovirus detections and typing. The Qiagen Rotor-Gene Q Platform is designed significantly differently in comparison to other real-time machines in the market. It has a unique centrifugal rotary design with a rotor that spins the samples. Heating/cooling is achieved by rapid airflow in the reaction chamber. No other machine can replace the Rotor-Gene Q Platform due to its unique design.
This contract action is for supplies or services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b) (SAP) and 10 U.S.C. 2304(c)(1). Interested persons may identify their interest and capability to respond to the requirement or submit proposals.
This notice of intent is not a request for competitive quotations; however, all quotations/responses received within fifteen (15) days of the issuance of this notice will be considered by the government. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to contract specialist at email@cdc.gov by 11:00EDT August 2, 2024.
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Notice of Intent to Sole Source a Thermo Orbitrap Fusion Lumos and Thermo RSLCnano UPLC Maintenance Agreement | CDC Office of Acquisition Services | No set-aside | |
| Intent to Sole Source - Medical/Scientific Instruments for the Department of Transfusion Medicine, NIH Clinical Center | National Institutes of Health | No set-aside | |
| Intent to Sole Source - BD FACSCanto II instrument | National Institutes of Health | No set-aside | |
| Notice of Intent to Sole Source – AB Sciex LLC | NIH Clinical Center | No set-aside | |
| Notice of Intent DNA Synthesizer | — | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity